Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus + Cyclophosphamide in Myxoid Liposarcoma and Chondrosarcoma
NCT02821507Phase 2Completed
- Sponsor
- Leiden University Medical Center
- Start
- Jun 2014
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of sirolimus in myxoid liposarcoma (MLPS) and chondrosarcoma, sponsored by Leiden University Medical Center. Primary endpoint: Time to Progression at 16 weeks. Started Jun 2014; status: completed.
02
Drugs
sirolimus
03
Conditions
myxoid liposarcoma (MLPS)chondrosarcoma
Beyond the preview
Go deeper on NCT02821507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02821507.